Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2013; 19(21): 3255-3262
Published online Jun 7, 2013. doi: 10.3748/wjg.v19.i21.3255
Published online Jun 7, 2013. doi: 10.3748/wjg.v19.i21.3255
Table 2 Patients population characteristics n (%)
| Variable | Non-liver transplanted cirrhotic group frequency(n= 43) | Liver transplanted cirrhotic group frequency(n= 17) | P |
| Age, yr (mean ± SD) | 55 ± 8 (39-69) | 57 ± 9 (38-73) | 0.753 |
| Sex | 0.073 | ||
| Male | 28 (65.1) | 15 (88.2) | |
| Female | 15 (34.9) | 2 (11.8) | |
| Genotype | 0.750 | ||
| 1 | 2 (58.1) | 11(64.7) | |
| 2 | 13 (30.2) | 3 (17.6) | |
| 3 | 2 (4.7) | 31 (5.9) | |
| 4 | 3 (7) | 2 (11.8) | |
| Previous treatment | 16 (37.2) | 4 (23.5) | 0.069 |
| HCV RNA 800000 (UI/mL) | 15 | 9 | 0.198 |
| EVR | 30 (69.8) | 8 (47.1) | 0.100 |
| SVR | 18 (41.9) | 5 (29.4) | 0.371 |
- Citation: Ponziani FR, Annicchiarico EB, Siciliano M, D’Aversa F, Pompili M, Gasbarrini A. Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation. World J Gastroenterol 2013; 19(21): 3255-3262
- URL: https://www.wjgnet.com/1007-9327/full/v19/i21/3255.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i21.3255